CD4+ T cells are able to reject class I disparate allografts

Transplantation. 1997 Jul 27;64(2):335-40. doi: 10.1097/00007890-199707270-00027.

Abstract

The ability of CD4+ T cells to reject class I mismatched skin allografts remains controversial. In this study, we compare the ability of CD4+ T cells to reject class I disparate skin grafts differing by either a single class I allelic disparity or only 3 amino acids encoded by the H-2K locus. We demonstrate that skin grafts across a full H-2K allelic disparity, but not across a disparity of only three amino acids are efficiently rejected by CD4+ T cells. This observation is consistent with the possibility that peptides derived from allogeneic class I molecules generated through the major histocompatibility complex (MHC) class II antigen processing pathway can be recognized by host CD4 T cells and lead to rejection of class I mismatched skin grafts. The availability of peptides derived from allogeneic MHC class I molecules for presentation by host MHC class II may determine the efficiency of rejection of class I mismatched allografts by CD4+ T cells. Thus, class I mismatched allografts can be rejected by CD4+ T cells provided that host and donor MHC class I molecules are sufficiently disparate to activate CD4+ effectors.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / physiology*
  • CD8-Positive T-Lymphocytes / physiology
  • Female
  • Graft Rejection / immunology
  • Graft vs Host Reaction
  • Histocompatibility Antigens Class I / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Skin Transplantation / immunology*

Substances

  • Histocompatibility Antigens Class I